Shimokawa T - Search Results

1

Phase Ib Study of Osimertinib Plus Ramucirumab in Japanese Lung Cancer Patients With EGFR Mutation.

Akamatsu H, Ozawa Y, Oyanagi J, Fujimoto D, Hata A, Katakami N, Tomii K, Murakami E, Sugimoto T, Shimokawa T, Koh Y, Yamamoto N. Akamatsu H, et al. Among authors: shimokawa t. Anticancer Res. 2021 Feb;41(2):911-917. doi: 10.21873/anticanres.14844. Anticancer Res. 2021. PMID: 33517297 Clinical Trial.

2

Randomized phase II trial of S-1 plus irinotecan versus S-1 plus paclitaxel as first-line treatment for advanced gastric cancer (OGSG0402).

Sugimoto N, Fujitani K, Imamura H, Uedo N, Iijima S, Imano M, Shimokawa T, Kurokawa Y, Furukawa H, Goto M. Sugimoto N, et al. Among authors: shimokawa t. Anticancer Res. 2014 Feb;34(2):851-7. Anticancer Res. 2014. PMID: 24511022 Clinical Trial.

3

Effect of Neoadjuvant Nab-Paclitaxel plus Gemcitabine Therapy on Overall Survival in Patients with Borderline Resectable Pancreatic Cancer: A Prospective Multicenter Phase II Trial (NAC-GA Trial).

Okada KI, Shimokawa T, Hirono S, Kawai M, Sho M, Satoi S, Matsumoto I, Eguchi H, Murakami Y, Yamada S, Doi M, Yamaue H; NAC-GA investigators. Okada KI, et al. Among authors: shimokawa t. Oncology. 2017;93(5):343-346. doi: 10.1159/000478660. Epub 2017 Jul 19. Oncology. 2017. PMID: 28719890 Clinical Trial.

4

Phase I/II Trial of Chemotherapy with Docetaxel, Cisplatin, and S-1 for Unresectable Advanced Squamous Cell Carcinoma of the Esophagus.

Ojima T, Nakamura M, Nakamori M, Katsuda M, Hayata K, Maruoka S, Shimokawa T, Yamaue H. Ojima T, et al. Among authors: shimokawa t. Oncology. 2018;95(2):116-120. doi: 10.1159/000488861. Epub 2018 May 16. Oncology. 2018. PMID: 29768280 Clinical Trial.

5

Randomized, Open-Label Phase II Study Comparing Capecitabine-Cisplatin Every 3 Weeks with S-1-Cisplatin Every 5 Weeks in Chemotherapy-Naïve Patients with HER2-Negative Advanced Gastric Cancer: OGSG1105, HERBIS-4A Trial.

Kawakami H, Takeno A, Endo S, Makari Y, Kawada J, Taniguchi H, Tamura S, Sugimoto N, Kimura Y, Tamura T, Fujitani K, Sakai D, Shimokawa T, Kurokawa Y, Satoh T. Kawakami H, et al. Among authors: shimokawa t. Oncologist. 2018 Dec;23(12):1411-e147. doi: 10.1634/theoncologist.2018-0175. Epub 2018 Aug 16. Oncologist. 2018. PMID: 30115736 Free PMC article. Clinical Trial.

6

Osimertinib With Ramucirumab in EGFR-mutated, T790M-positive Patients With Progression During EGFR-TKI Therapy: Phase Ib Study.

Akamatsu H, Koh Y, Ozawa Y, Fujimoto D, Hata A, Katakami N, Tomii K, Shimokawa T, Yamamoto N. Akamatsu H, et al. Among authors: shimokawa t. Clin Lung Cancer. 2018 Nov;19(6):e871-e874. doi: 10.1016/j.cllc.2018.08.001. Epub 2018 Aug 22. Clin Lung Cancer. 2018. PMID: 30197264 Free article.

7

Trastuzumab With S-1 Plus Cisplatin in HER2-positive Advanced Gastric Cancer Without Measurable Lesions: OGSG 1202.

Endo S, Kurokawa Y, Gamoh M, Kimura Y, Matsuyama J, Taniguchi H, Takeno A, Kawabata R, Kawada J, Masuzawa T, Yamamoto K, Kobayashi K, Sakai D, Shimokawa T, Satoh T. Endo S, et al. Among authors: shimokawa t. Anticancer Res. 2019 Feb;39(2):1059-1065. doi: 10.21873/anticanres.13213. Anticancer Res. 2019. PMID: 30711995 Clinical Trial.

8

Efficacy and Safety of Enoxaparin for Prophylaxis of Postoperative Venous Thromboembolism After Esophagectomy: A Single-center Prospective Randomized Controlled Phase II Study.

Tanaka Y, Yamada A, Hirata S, Tanaka H, Sakuratani T, Matsuhashi N, Yamaguchi K, Shimokawa T, Yoshida K. Tanaka Y, et al. Among authors: shimokawa t. Anticancer Res. 2019 May;39(5):2615-2625. doi: 10.21873/anticanres.13385. Anticancer Res. 2019. PMID: 31092460 Clinical Trial.

9

Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002).

Fujitani K, Tamura S, Kimura Y, Matsuyama J, Imamura H, Yamamoto K, Fujita J, Iijima S, Ueda S, Kurokawa Y, Shimokawa T, Satoh T; Osaka Gastrointestinal Cancer Chemotherapy Study Group. Fujitani K, et al. Among authors: shimokawa t. Gastric Cancer. 2020 May;23(3):520-530. doi: 10.1007/s10120-019-01023-w. Epub 2019 Oct 30. Gastric Cancer. 2020. PMID: 31667688 Clinical Trial.

10

Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled trial.

Murakami E, Akamatsu H, Shimokawa T, Wada K, Yamamoto N. Murakami E, et al. Among authors: shimokawa t. BMJ Open. 2019 Dec 11;9(12):e029057. doi: 10.1136/bmjopen-2019-029057. BMJ Open. 2019. PMID: 31831529 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

755 results

Search Page